CRL · Earnings call · 2026Q2T · Full report
Capital Return Program
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-08-05 · Importance 52 · Surprise 42 · In source text
Charles River repurchased $100 million of shares in the second quarter at approximately $174 per share. Year-to-date repurchases reached $300 million under the $1 billion authorization approved in October 2025. Management said capital deployment is being balanced among organic investment, strategic acquisitions, debt repayment, and shareholder returns. The updated full-year guidance assumes an average diluted share count of approximately 48.5 million shares.
Key facts
- Charles River repurchased $100 million in shares at approximately $174 per share in the second quarter under the $1 billion stock repurchase authorization approved last October, bringing year-to-date repurchases to $300 million.
- The company assumes an average diluted share count of approximately 48.5 million shares for full year 2026 in its updated guidance.
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | realized | -1.3% | Charles River repurchased $100 million in shares at approximately $174 per share in the second quarter under the $1 billion stock… |